2-es típusú cukorbetegség: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• GLP-1 66
• SGLT2 40
• PPAR 0
• AMPK 2
• DPP-4 7
• PI3K 0
• AKT 0
• GIP 4
• mTOR 0
• NRF2 0
• NLRP3 3
• SIRT1 1
• STAT3 0
• TP53 1
• TNF 0
• MAPK 0
• PCSK9 1
• VEGF 2
• JNK 0
• TLR4 0
• FTO 0
• IL-6 2
• ERK 0
• HIF-1 0
• JAK 0
• HMGB1 0
• APOE 0
• BDNF 0
• IL-1 1
• STING 0
• CTNNB1 0
• GPX4 0
• PTEN 0
• STK11 0
• IL-17 1
• MMP-9 1
• BCL-2 0
• COX-2 0
• MEK 0
• PINK1 0
• CD40 0
• EGFR 0
• PD-1 0
• RANKL 0
• YAP 0
• ATM 0
• FGFR 0
• MET 1
• PD-L1 0
• SNCA 0
• CCR5 0
• CDKN2A 0
• CXCR4 0
• IGF1R 0
• MAPT 0
• METTL3 0
• PNPLA3 0
• ABL1 0
• BACE1 0
• CD38 0

6427 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Glutaminase Isoenzymes: Gatekeepers of Bioenergetics, Immunity, and Tumor Microenvironment in Diabetes-Induced Hepatocellular Carcinoma (IRM)

  Fundacion Para la Investigacion de Malaga En Biomedicina y Salud· Malaga, Spanyolország· EU contribution 209 915 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unmasking the Perivascular Adipose Tissue's Role in Diabetic Vascular Disease From Molecular Clues to Clinical Impact (IMAPERFAT)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 236 340 EUR· until 2029. márc.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Bridging Chronobiology and Physiology through Expert Training (ChronoBridge)

  Ecole Polytechnique Federale de Lausanne· Lausanne, Svájc· EU contribution 3 885 022 EUR· until 2030. dec.· 9 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  AI-Powered and Robot-Assisted Opto-Acoustic Evaluation of Systemic Microangiopathy for Ulcer Healing Outcomes in Type 2 Diabetes (ARETEOS)

  Universitatsklinikum Erlangen· Erlangen, Németország· EU contribution 1 499 068 EUR· until 2031. dec.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  First-in-man beta-cell regeneration for causal type 2 diabetes therapy (BetaProtect)

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 150 000 EUR· until 2028. ápr.

5 of 59 running projects, newest first. Listed amounts together: 152,4 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Felfüggesztve

  Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

  NCT01105858· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Frissítve: 2026. nov. 12.

  “Recruitment temporarily paused.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Assessing Continuous Glucose Monitor Use in Underserved Primary Care Patients

  NCT05766488· University of Nebraska· Frissítve: 2026. nov. 12.

  “poor accrual”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Combined Circulatory and Dietary Interventions for Neuropathy

  NCT07213843· Loma Linda University· Frissítve: 2026. nov. 10.

  “Study was never initiated/no study participants were ever enrolled/study was never funded.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Small Bowel Diversion

  NCT06374368· University of Ostrava· Frissítve: 2026. nov. 6.

  “Halted for safety concerns after jejuno-colic diversion: frequent and serious late complications, incl. hepatic fibrosis, lean body mass loss and surgical reversal of the anastomosis.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm

  NCT07066891· Sun Yat-sen University· Frissítve: 2026. okt. 20.

  “Recruitment was stopped early because hospital length-of-stay constraints limited protocol delivery. The PI's decision also took account of the available non-inferiority results.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency

  NCT07786571· Sun Yat-sen University· Frissítve: 2026. okt. 16.

  “The study was withdrawn because the protocol was revised and would be replaced by an updated study design, prior to participant enrollment.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation

  NCT07677865· West China Hospital· Frissítve: 2026. okt. 16.

  “poor accrual and funding issues”A regiszter szövege, változtatás nélkül. Forrás

• Felfüggesztve

  PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

  NCT07636161· University of Miami· Frissítve: 2026. szept. 28.

  “The sponsor has communicated that they may no longer fund this research study. Pending final confirmation if the study will be closed.”A regiszter szövege, változtatás nélkül. Forrás

• Visszavonták

  Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

  NCT03508739· University of Pennsylvania· Frissítve: 2026. szept. 21.

  “We do not have active funding.”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  A Nutritional Intervention in Police Officers

  NCT02651480· Physicians Committee for Responsible Medicine· Frissítve: 2026. szept. 17.

  “Sponsor put plans on hold”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Boehringer Ingelheim· Forrás

• AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

  NCT07931573· Novo Nordisk A/S· Forrás

• A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

  NCT07931495· Novo Nordisk A/S· Forrás

• A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants

  NCT07024823· AstraZeneca· Forrás

• A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes

  NCT07112872· Hoffmann-La Roche· Forrás

• A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both

  NCT07931599· Novo Nordisk A/S· Forrás

• Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes

  NCT07375797· Central Jutland Regional Hospital· Forrás

• A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both

  NCT07931547· Novo Nordisk A/S· Forrás

• Molecular and Clinical Profile of Diabetes Mellitus and Its Complications

  NCT01105858· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Forrás

• Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects With Type 2 Diabetes

  NCT06895018· Federico II University· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 26
• Organoids 3
• Mendelian Randomization Analysis 228
• CRISPR-Cas Systems 5
• Gene Expression Profiling 113
• Sequence Analysis, RNA 8
• Whole Genome Sequencing 8
• Exome Sequencing 12
• Proteomics 148
• Metabolomics 202
• Mass Spectrometry 42
• Flow Cytometry 19
• Immunohistochemistry 50
• Xenograft Model Antitumor Assays 34
• Positron-Emission Tomography 31
• Magnetic Resonance Imaging 186
• Machine Learning 195
• Deep Learning 32
• Cohort Studies 1111
• Genome-Wide Association Study 315

• Analysis of Whole Exome Sequencing Results of Type 2 Diabetic Pedigree.

  Mol Genet Genomic Med, 2026. okt.

• Genetics and clinical landscape of pediatric monogenic diabetes in consanguineous cohort: high diagnostic yield and recessive burden.

  Diabetes Res Clin Pract, 2026. júl.

• Genomic landscape of Mexican patients with maturity onset diabetes of the young: beyond mutations in MODY-known genes.

  Front Endocrinol (Lausanne), 2026. júl.

• Identification and functional characterization of a novel mutation in the NEUROD1 gene in a Chinese family with maturity-onset diabetes of the young.

  Acta Diabetol, 2026. jún.

• Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.

  Nat Med, 2026. jún.

• [Clinical and genetic analysis of a patient with Alström syndrome presenting with paroxysmal palpitations].

  Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2026. máj.

• Identification of novel genomic variants in diabetic nephropathy patients using whole-exome sequencing: a pilot investigation.

  Front Endocrinol (Lausanne), 2026. márc.

• Molecular diagnosis of maturity-onset diabetes of the young via whole-exome sequencing: a cohort study in Taizhou, China.

  Endocrine, 2026. márc.

• Search for the most precise diagnosis of monogenic diabetes - the usefulness of short-read NGS method in molecular testing in Polish patients.

  Acta Diabetol, 2026. febr.

• Deciphering Silence: Functional Studies of GCK Synonymous and Nonsense Variants and Their Importance in Understanding Diabetes.

  Genes (Basel), 2026. febr.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.